Wall Street Analyst Forum's 47th Institutional Investor Conference
events.onlinebroadcasting.com/fdfn/wsaf/...p?mode=1&sel_date=1
10.Februar
38 Minuten,anscheinend hat er was gesagt über Vertagung der Anerkennung durch FDA für den einen Schnelltest,wird im Bord behauptet
Ausserdem hat Calypte mit Aktien bezahlt für die Public-Relationarbeit durch LLC:According to the OTC Journal disclaimer, MarketByte, LLC has been compensated a fee of 250,000 free trading shares of Calypte common stock by First Stage Capital for coverage of Calypte Biomed. On August 12, 2002, MarketByte LLC entered into an agreement directly with Calypte Biomed to continue coverage of the company through October 31, 2002. Calypte Biomed paid $25,000 cash as compensation, and an additional 300,000 shares of free trading stock were paid by a third party on behalf of the company. On November 1, 2002, MarketByte LLC and Calypte Biomed to agreed to renew the agreement to extend through January 31, 2003 in return for a pledge by Calypte Biomed to pay $25,000 in cash, and an additional 300,000 shares of free trading stock were pledged by a third party.
OTCJournal wunderte sich über den starken Anstieg von CALY